Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Nucleus membrane; Multi-pass membrane protein. Cell membrane Multi-pass membrane protein Cytoplasm Membrane, caveola Note=Location at the nuclear membrane facilitates heterooligomerization and regulates ERK-mediated signaling in cardiac myocytes. Colocalizes with GNAQ, PLCB1 as well as LAP2 at the nuclear membrane of cardiac myocytes. |
Domain |
PF00001 7 transmembrane receptor (rhodopsin family) |
Function |
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes. |
Biological Process |
GO:0001508 action potential GO:0001976 neurological system process involved in regulation of systemic arterial blood pressure GO:0001978 regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback GO:0001983 baroreceptor response to increased systemic arterial blood pressure GO:0001985 negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure GO:0001993 regulation of systemic arterial blood pressure by norepinephrine-epinephrine GO:0001994 norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure GO:0001996 positive regulation of heart rate by epinephrine-norepinephrine GO:0001997 positive regulation of the force of heart contraction by epinephrine-norepinephrine GO:0002026 regulation of the force of heart contraction GO:0002027 regulation of heart rate GO:0003012 muscle system process GO:0003013 circulatory system process GO:0003014 renal system process GO:0003015 heart process GO:0003018 vascular process in circulatory system GO:0003025 regulation of systemic arterial blood pressure by baroreceptor feedback GO:0003044 regulation of systemic arterial blood pressure mediated by a chemical signal GO:0003057 regulation of the force of heart contraction by chemical signal GO:0003073 regulation of systemic arterial blood pressure GO:0003084 positive regulation of systemic arterial blood pressure GO:0003085 negative regulation of systemic arterial blood pressure GO:0003099 positive regulation of the force of heart contraction by chemical signal GO:0003321 positive regulation of blood pressure by epinephrine-norepinephrine GO:0006816 calcium ion transport GO:0006874 cellular calcium ion homeostasis GO:0006875 cellular metal ion homeostasis GO:0006936 muscle contraction GO:0006937 regulation of muscle contraction GO:0006939 smooth muscle contraction GO:0006940 regulation of smooth muscle contraction GO:0006941 striated muscle contraction GO:0006942 regulation of striated muscle contraction GO:0007187 G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007188 adenylate cyclase-modulating G-protein coupled receptor signaling pathway GO:0007189 adenylate cyclase-activating G-protein coupled receptor signaling pathway GO:0007200 phospholipase C-activating G-protein coupled receptor signaling pathway GO:0007202 activation of phospholipase C activity GO:0007204 positive regulation of cytosolic calcium ion concentration GO:0007265 Ras protein signal transduction GO:0007266 Rho protein signal transduction GO:0007270 neuron-neuron synaptic transmission GO:0007507 heart development GO:0007512 adult heart development GO:0007568 aging GO:0007588 excretion GO:0008015 blood circulation GO:0008016 regulation of heart contraction GO:0008217 regulation of blood pressure GO:0010459 negative regulation of heart rate GO:0010460 positive regulation of heart rate GO:0010517 regulation of phospholipase activity GO:0010518 positive regulation of phospholipase activity GO:0010863 positive regulation of phospholipase C activity GO:0016049 cell growth GO:0019229 regulation of vasoconstriction GO:0032228 regulation of synaptic transmission, GABAergic GO:0032230 positive regulation of synaptic transmission, GABAergic GO:0035023 regulation of Rho protein signal transduction GO:0035024 negative regulation of Rho protein signal transduction GO:0035150 regulation of tube size GO:0035265 organ growth GO:0042310 vasoconstriction GO:0042391 regulation of membrane potential GO:0042493 response to drug GO:0043410 positive regulation of MAPK cascade GO:0044057 regulation of system process GO:0045760 positive regulation of action potential GO:0045776 negative regulation of blood pressure GO:0045777 positive regulation of blood pressure GO:0045822 negative regulation of heart contraction GO:0045823 positive regulation of heart contraction GO:0045907 positive regulation of vasoconstriction GO:0045933 positive regulation of muscle contraction GO:0045987 positive regulation of smooth muscle contraction GO:0045989 positive regulation of striated muscle contraction GO:0046578 regulation of Ras protein signal transduction GO:0046580 negative regulation of Ras protein signal transduction GO:0050804 modulation of synaptic transmission GO:0050806 positive regulation of synaptic transmission GO:0050880 regulation of blood vessel size GO:0051056 regulation of small GTPase mediated signal transduction GO:0051058 negative regulation of small GTPase mediated signal transduction GO:0051480 regulation of cytosolic calcium ion concentration GO:0051932 synaptic transmission, GABAergic GO:0055074 calcium ion homeostasis GO:0055117 regulation of cardiac muscle contraction GO:0060004 reflex GO:0060047 heart contraction GO:0060048 cardiac muscle contraction GO:0060073 micturition GO:0060191 regulation of lipase activity GO:0060193 positive regulation of lipase activity GO:0060401 cytosolic calcium ion transport GO:0060402 calcium ion transport into cytosol GO:0060452 positive regulation of cardiac muscle contraction GO:0070371 ERK1 and ERK2 cascade GO:0070372 regulation of ERK1 and ERK2 cascade GO:0070374 positive regulation of ERK1 and ERK2 cascade GO:0070528 protein kinase C signaling GO:0070838 divalent metal ion transport GO:0071875 adrenergic receptor signaling pathway GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway GO:0072503 cellular divalent inorganic cation homeostasis GO:0072507 divalent inorganic cation homeostasis GO:0072511 divalent inorganic cation transport GO:0090036 regulation of protein kinase C signaling GO:0090037 positive regulation of protein kinase C signaling GO:0090066 regulation of anatomical structure size GO:0090257 regulation of muscle system process GO:0097195 pilomotor reflex GO:0098900 regulation of action potential GO:1900274 regulation of phospholipase C activity GO:1902532 negative regulation of intracellular signal transduction GO:1903522 regulation of blood circulation GO:1903523 negative regulation of blood circulation GO:1903524 positive regulation of blood circulation |
Molecular Function |
GO:0004935 adrenergic receptor activity GO:0004936 alpha-adrenergic receptor activity GO:0004937 alpha1-adrenergic receptor activity GO:0008227 G-protein coupled amine receptor activity GO:0046982 protein heterodimerization activity |
Cellular Component |
GO:0005635 nuclear envelope GO:0030016 myofibril GO:0030017 sarcomere GO:0030018 Z disc GO:0030315 T-tubule GO:0031674 I band GO:0031965 nuclear membrane GO:0042383 sarcolemma GO:0043292 contractile fiber GO:0044449 contractile fiber part |
KEGG |
hsa04020 Calcium signaling pathway hsa04022 cGMP-PKG signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04152 AMPK signaling pathway hsa04261 Adrenergic signaling in cardiomyocytes hsa04270 Vascular smooth muscle contraction hsa04970 Salivary secretion |
Reactome |
R-HSA-390696: Adrenoceptors R-HSA-375280: Amine ligand-binding receptors R-HSA-373076: Class A/1 (Rhodopsin-like receptors) R-HSA-416482: G alpha (12/13) signalling events R-HSA-416476: G alpha (q) signalling events R-HSA-388396: GPCR downstream signaling R-HSA-500792: GPCR ligand binding R-HSA-881907: Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-162582: Signal Transduction R-HSA-372790: Signaling by GPCR |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between ADRA1A and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of ADRA1A in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of ADRA1A in various data sets.
|
Points in the above scatter plot represent the mutation difference of ADRA1A in various data sets.
|
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of ADRA1A. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of ADRA1A. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by ADRA1A. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of ADRA1A. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of ADRA1A expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between ADRA1A and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | ADRA1A |
Name | adrenoceptor alpha 1A |
Aliases | ADRA1L1; ADRA1C; ALPHA1AAR; G protein coupled receptor; adrenergic, alpha-1A-, receptor variant 1; adrenergi ...... |
Chromosomal Location | 8p21.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting ADRA1A collected from DrugBank database. |
Details on drugs targeting ADRA1A.
|